M. Basche

Assessment of the biological and pharmacological effects of the ανβ3 and ανβ5 integrin receptor antagonist, cilengitide (EMD 121974), in patients with advanced solid tumors

Seetharaman Hariharan, Daniel L. Gustafson, Scott N. Holden et al. · Annals of Oncology · 2007 · 122 citations

Molecular Pharmacology, Oncology, Chemoprevention Strategy +11

A Phase I Biological and Pharmacologic Study of the Heparanase Inhibitor PI-88 in Patients with Advanced Solid Tumors

M. Basche, Daniel L. Gustafson, Scott N. Holden et al. · Clinical Cancer Research · 2006 · 95 citations

Expression, nucleotide sequence and mutational analysis of two open reading frames in the nif gene region of Anabaena sp. strain PCC 7120

Dulal Borthakur, M. Basche, William J. Buikema et al. · Molecular and General Genetics MGG · 1990 · 71 citations

Nif Gene Region, Genetics, Sequence Analysis +9

Barriers to Enrollment of Elderly Adults in Early-Phase Cancer Clinical Trials

M. Basche, Anna E. Barón, Sabine Eckhardt et al. · Journal of Oncology Practice · 2008 · 67 citations · Full text

A Multicenter, Phase I, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of Etirinotecan Pegol in Patients with Refractory Solid Tumors

Gayle Jameson, John Hamm, Glen J. Weiss et al. · Clinical Cancer Research · 2012 · 53 citations · Full text